Matches in SemOpenAlex for { <https://semopenalex.org/work/W1943648506> ?p ?o ?g. }
- W1943648506 endingPage "7" @default.
- W1943648506 startingPage "291" @default.
- W1943648506 abstract "LY320135 is a selective antagonist for the brain CB1 receptor, having greater than 70-fold higher affinity for the CB1 than the peripheral CB2 receptor. The Ki values for LY320135 at the CB1 and CB2 receptors, transfected and stably expressed in cell lines, were 224 nM and > 10 microM, respectively. Similar Ki values were measured in binding studies performed on cerebellum and spleen membrane preparations endogenously expressing the CB1 (203 nM) and CB2 (> 10 microM) receptors, respectively. LY320135 functionally reversed anandamide-mediated adenylate cyclase inhibition in Chinese hamster ovary (CHO) cells stably expressing the CB1 receptor. Pertussis toxin treatment of CHO cells expressing the CB1 receptor attenuated the anandamide-mediated inhibition of adenylate cyclase and unmasked a stimulatory effect of anandamide on adenylate cyclase. The stimulatory component was blocked with LY320135. This compound also blocked WIN 55212-2-mediated inhibition of N-type calcium channels and activation of inwardly rectifying potassium channels in N18 and AtT-20-CB2 cells, respectively. LY320135 is a promising lead compound for the further development of novel, potent and selective cannabinoid antagonists of novel structure." @default.
- W1943648506 created "2016-06-24" @default.
- W1943648506 creator A5009397956 @default.
- W1943648506 creator A5010858252 @default.
- W1943648506 creator A5013032842 @default.
- W1943648506 creator A5043775077 @default.
- W1943648506 creator A5044150692 @default.
- W1943648506 creator A5052855527 @default.
- W1943648506 creator A5055886971 @default.
- W1943648506 creator A5071307515 @default.
- W1943648506 creator A5071484079 @default.
- W1943648506 creator A5075104864 @default.
- W1943648506 creator A5082267704 @default.
- W1943648506 creator A5084369395 @default.
- W1943648506 date "1998-01-01" @default.
- W1943648506 modified "2023-09-27" @default.
- W1943648506 title "LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation." @default.
- W1943648506 cites W1604214492 @default.
- W1943648506 cites W1670633125 @default.
- W1943648506 cites W1828678105 @default.
- W1943648506 cites W1832918544 @default.
- W1943648506 cites W1836729582 @default.
- W1943648506 cites W1844090762 @default.
- W1943648506 cites W1855443240 @default.
- W1943648506 cites W1911828734 @default.
- W1943648506 cites W1936496610 @default.
- W1943648506 cites W1969583788 @default.
- W1943648506 cites W1975751192 @default.
- W1943648506 cites W1985729616 @default.
- W1943648506 cites W1989073099 @default.
- W1943648506 cites W2000943096 @default.
- W1943648506 cites W2003594380 @default.
- W1943648506 cites W2009667219 @default.
- W1943648506 cites W2011161535 @default.
- W1943648506 cites W2018953051 @default.
- W1943648506 cites W2020827621 @default.
- W1943648506 cites W2031406492 @default.
- W1943648506 cites W2044281547 @default.
- W1943648506 cites W2056188558 @default.
- W1943648506 cites W2057054987 @default.
- W1943648506 cites W2059977407 @default.
- W1943648506 cites W2065241852 @default.
- W1943648506 cites W2075894678 @default.
- W1943648506 cites W2083371696 @default.
- W1943648506 cites W2200751586 @default.
- W1943648506 cites W2266381978 @default.
- W1943648506 cites W2271360766 @default.
- W1943648506 cites W2308715768 @default.
- W1943648506 cites W2409586977 @default.
- W1943648506 cites W2413006285 @default.
- W1943648506 cites W2415972133 @default.
- W1943648506 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9435190" @default.
- W1943648506 hasPublicationYear "1998" @default.
- W1943648506 type Work @default.
- W1943648506 sameAs 1943648506 @default.
- W1943648506 citedByCount "68" @default.
- W1943648506 countsByYear W19436485062012 @default.
- W1943648506 countsByYear W19436485062014 @default.
- W1943648506 countsByYear W19436485062015 @default.
- W1943648506 countsByYear W19436485062016 @default.
- W1943648506 countsByYear W19436485062017 @default.
- W1943648506 countsByYear W19436485062018 @default.
- W1943648506 countsByYear W19436485062019 @default.
- W1943648506 countsByYear W19436485062021 @default.
- W1943648506 countsByYear W19436485062022 @default.
- W1943648506 crossrefType "journal-article" @default.
- W1943648506 hasAuthorship W1943648506A5009397956 @default.
- W1943648506 hasAuthorship W1943648506A5010858252 @default.
- W1943648506 hasAuthorship W1943648506A5013032842 @default.
- W1943648506 hasAuthorship W1943648506A5043775077 @default.
- W1943648506 hasAuthorship W1943648506A5044150692 @default.
- W1943648506 hasAuthorship W1943648506A5052855527 @default.
- W1943648506 hasAuthorship W1943648506A5055886971 @default.
- W1943648506 hasAuthorship W1943648506A5071307515 @default.
- W1943648506 hasAuthorship W1943648506A5071484079 @default.
- W1943648506 hasAuthorship W1943648506A5075104864 @default.
- W1943648506 hasAuthorship W1943648506A5082267704 @default.
- W1943648506 hasAuthorship W1943648506A5084369395 @default.
- W1943648506 hasConcept C126322002 @default.
- W1943648506 hasConcept C134018914 @default.
- W1943648506 hasConcept C148001335 @default.
- W1943648506 hasConcept C158026453 @default.
- W1943648506 hasConcept C170493617 @default.
- W1943648506 hasConcept C175656101 @default.
- W1943648506 hasConcept C185592680 @default.
- W1943648506 hasConcept C2776885963 @default.
- W1943648506 hasConcept C2778122271 @default.
- W1943648506 hasConcept C2779783865 @default.
- W1943648506 hasConcept C2780871563 @default.
- W1943648506 hasConcept C46721173 @default.
- W1943648506 hasConcept C55493867 @default.
- W1943648506 hasConcept C61372379 @default.
- W1943648506 hasConcept C71924100 @default.
- W1943648506 hasConcept C86803240 @default.
- W1943648506 hasConcept C93248783 @default.
- W1943648506 hasConcept C98274493 @default.
- W1943648506 hasConceptScore W1943648506C126322002 @default.
- W1943648506 hasConceptScore W1943648506C134018914 @default.